Olivier Danos
2019
In 2019, Olivier Danos earned a total compensation of $1.9M as EVP, Chief Scientific Officer at Regenxbio, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,359 |
|---|---|
| Option Awards | $1,303,691 |
| Salary | $421,270 |
| Other | $16,100 |
| Total | $1,926,420 |
Danos received $1.3M in option awards, accounting for 68% of the total pay in 2019.
Danos also received $185.4K in non-equity incentive plan, $421.3K in salary and $16.1K in other compensation.
Rankings
In 2019, Olivier Danos' compensation ranked 6,135th out of 13,971 executives tracked by ExecPay. In other words, Danos earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,135 out of 13,971 | 56th |
Division Manufacturing | 2,301 out of 5,695 | 60th |
Major group Chemicals And Allied Products | 835 out of 2,194 | 62nd |
Industry group Drugs | 704 out of 1,880 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 166 out of 389 | 57th |
Source: SEC filing on April 7, 2022.
Danos' colleagues
We found four more compensation records of executives who worked with Olivier Danos at Regenxbio in 2019.